Alixia Company Information

Alixia, previously named Guided Clarity, is a healthcare company located in San Francisco, CA, operating within the therapeutics sub-industry. Founded by Olof Mollstedt and Helen Chen, Ph.D., the company is part of the Y-Combinator W22 batch and focuses on the American and Canadian markets. The team, consisting of two members, leverages an integrated approach combining biology, biophysics, computational chemistry, and clinical insights to innovate in the treatment of cancer, aging, inflammation, and immune dysregulation. Their therapeutic portfolio includes multiple programs in preclinical development aimed at disrupting metabolic and inflammatory triggers in cancerous and quasi-cancerous cells. Olof Mollstedt, co-founder, holds B.S. and M.S. degrees in Engineering Physics from Chalmers University of Technology and École Polytechnique Fédérale de Lausanne. Helen Chen, co-founder and a veteran in biotech with over 15 years of experience, previously served as COO at Ambryx Biotechnology and holds a B.S. from Yale University and a Ph.D. from UCSD, School of Medicine.

Still processing data for company.

2 people indexed:

Unlock exclusive insights

Sign up to reveal more information.

Sign up for free